Abstract: Disclosed is the use of a HIF-? potentiating agent and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for mobilizing hematopoietic stem cell and progenitor cells from the bone marrow into the peripheral blood. The compositions and methods are particularly useful for stem cell transplantation and for treating or preventing immune deficiencies.
Type:
Application
Filed:
November 4, 2013
Publication date:
January 21, 2016
Applicant:
MATER MEDICAL RESEARCH INSTITUTE LIMITED
Inventors:
Jean-Pierre Jose Rene Levesque, Ingrid Gabriele WINKLER
Abstract: This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular useful for prophylaxis and/or treatment of hematopoietic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.